Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3524-3530

  Naber, C K ^a   Hammer, M ^a   Kinzig Schippers, M ^a   Sauber, C ^a   Sorgel F ^a   Bygate, E A ^a   Fairless, A J ^a   Machka, K ^a   Naber, K G ^a  

^a Urologische Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GEMIFLOXACIN; OFLOXACIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG EXCRETION; DRUG INDICATION; DRUG URINE LEVEL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; URINARY EXCRETION; URINARY TRACT INFECTION; VOLUNTEER;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CALIBRATION; CROSS-OVER STUDIES; FEMALE; FLUOROQUINOLONES; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; OFLOXACIN; QUALITY CONTROL; URINE;

EID: 0035185193     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3524-3530.2001     Document Type: Article

References (13)

1. Multiple dose pharmacokinetics and tolerability of gemifloxacin following oral doses to healthy volunteers
2. Pharmacokinetics and tolerability of gemifloxacin after administration of single oral doses to healthy volunteers
3. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antimicrobial peak concentration to MIC for bactericidal activity and emergence of resistance
4. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
5. Rapid determination of gemifloxacin in human plasma by high performance liquid chromatography-tandem mass spectrometry
6. Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800 mg oral dose
7. Antibacterial activity of antibacterial agents in urine
8. Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg
9. Urinary excretion and bacterial activities of a single oral dose of 400 mg of fleroxacin versus a single oral dose of 800 mg of pefloxacin in healthy volunteers
10. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics
11. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose